−0.035CAD
−2.79 MCAD
33.04 M
About RAKOVINA THERAPEUTICS INC
Sector
Industry
Headquarters
Vancouver
Website
Employees (FY)
10
Founded
2020
ISIN
CA75103L1013
FIGI
BBG00RN62JS7
Rakovina Therapeutics, Inc. focuses on the development of new cancer treatments based on novel DNA-damage response technologies. It engages in developing precision medicines that selectively target and kill cancer cells using science to discover and advance innovative cancer treatments with the potential to improve patient outcomes across multiple tumor types. The company was founded in 2020 and is headquartered in Vancouver, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of RKV is 0.090 CAD — it has decreased by 5.26% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange RAKOVINA THERAPEUTICS INC stocks are traded under the ticker RKV.
RKV stock is 5.56% volatile and has beta coefficient of 0.17. Check out the list of the most volatile stocks — is RAKOVINA THERAPEUTICS INC there?
Yes, you can track RAKOVINA THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
RKV stock has risen by 5.88% compared to the previous week, the month change is a 28.57% rise, over the last year RAKOVINA THERAPEUTICS INC has showed a 41.94% decrease.
RKV net income for the last quarter is −646.97 K CAD, while the quarter before that showed −601.40 K CAD of net income which accounts for −7.58% change. Track more RAKOVINA THERAPEUTICS INC financial stats to get the full picture.
No, RKV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RKV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RAKOVINA THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 10.00 employees. See our rating of the largest employees — is RAKOVINA THERAPEUTICS INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RAKOVINA THERAPEUTICS INC technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RAKOVINA THERAPEUTICS INC stock shows the sell signal. See more of RAKOVINA THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.